Evaluate the Effectiveness and Safety of a Cryogenic Pen to Treat Skin Tags Versus a Comparator.
ConditionSkin Tags
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorOystershell NV
About this trial
The purpose of this clinical investigation is to evaluate the effectiveness and safety of Nitrofreeze Skin Tag for the treatment of skin tags versus a comparator device (Scholl Freeze Away® Skin Tag Remover).
Eligibility criteria
Qualifiers
Healthy subject.
Sex: male or female.
Age: more than 22 years old.
Phototype: I to III according to Fitzpatrick.
Disqualifiers
Pregnant or nursing woman or planning a pregnancy during the study.
Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
Subject in a social or sanitary establishment.
Subject having received 6000 euros indemnities for participation in clinical research in the 12 previous months, including participation in the present study.
Trial design
Treatments tested in this trial
- NITROFREEZE Skin tag
- Scholl Freeze Away Skin Tag Remover
Treatment groups
56 Participants
are divided into 2 treatment groupsSponsors and collaborators
Oystershell NV
Lead sponsor
Eurofins Dermscan Pharmascan
Collaborator
Source ClinicalTrials.gov